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AbsTrACT
background Equitable access to research studies needs 
to be increased for all patients. There is debate about 
which is the best approach to use to discuss participation 
in research in real-world clinical settings.
Objective We aimed to determine the feasibility of 
asking all clinical staff within one hospital Trust (an 
organisation that provides secondary health services 
within the English and Welsh National Health Service) to 
use a newly created form on the Trust’s electronic patient 
records system, as a means of asking patients to consent 
to discuss participation in research (the opt-in approach). 
We also aimed to collect feedback from patients and 
clinicians about their views of the opt-in approach.
Methods Four pilot sites were selected in the Trust: 
two memory clinics, an adult mental health team and an 
acute adult ward. Data were collected in three phases: 
(1) for 6 months, pilot site staff were asked to complete 
a consent to discuss participation in research form with 
patients; (2) staff feedback on the form was collected 
through an online survey; and (3) patient feedback was 
collected through focus groups.
Findings Of 1779 patients attending services during 
the pilot period, 197 (11%) had a form completed 
by staff and 143 (8%) opted-in to finding out about 
research. Staff cited limited time, low priority and poor 
user experience of the electronic patient records system 
as reasons for low uptake of the form. Patients generally 
approved of the approach but offered suggestions for 
improvement.
Conclusions There were mixed results for adopting an 
opt-in approach; uptake was very low, limiting its value 
as an effective strategy for improving access to research.
Clinical implications Alternative strategies to the 
opt-in approach, such as transparent opt out approaches, 
warrant consideration to maximise access to research 
within routine clinical care.
bACkgrOund
Patients who take part in research generally have 
improved clinical outcomes, while research active 
clinical services have lower mortality rates and 
also have superior overall clinical performance.1 
However, recruitment to research within the UK 
National Health Service (NHS) is challenging 
and involves many barriers, especially in mental 
health.2 One key barrier is that researchers often 
are not permitted to contact patients directly about 
research due to concerns about confidentiality, data 
protection and patient vulnerability; this can have a 
detrimental impact on recruitment rates.3
Researchers are largely dependent on clini-
cian referrals to recruit participants to studies, 
but these referrals are influenced by busy clini-
cians’ understanding of research study protocols 
and their attitudes and beliefs around the benefits 
of research.4 Clinicians who hold dual academic/
clinical roles are more likely to refer patients to 
research studies,5 6 thus research participants often 
only represent patients from a small numbers of 
clinicians, rather than being representative of the 
general clinical population.
New strategies to improve access to research 
for all patients became a key priority for Oxford 
Health NHS Foundation Trust (OHFT), when 
it gained National Institute for Health Research 
Biomedical Research Centre status in 2017. A Trust 
is an organisation that provides secondary health 
services within the English and Welsh NHS. One 
potential strategy for increasing recruitment rates 
was to adopt an opt-in approach, in which the 
patient’s clinician seeks consent to discuss their 
participation in research (CDPR). To be successful, 
this process needs to ensure that all patients are 
properly informed about the benefits of research 
participation, as well as training all clinical staff to 
introduce research opportunities to patients.
Integrating an opt-in approach into clinical prac-
tice requires the recording of patient consent. At 
OHFT, an electronic patient records system (EPR) 
used by clinical staff within the trust was used for 
this purpose. A new form was added to EPR where 
CDPR could be recorded, thus simplifying the data 
collection process and improving access to the 
CDPR form for staff members.
The CDPR form (online supplementary appendix 
1) was developed after consultation with key stake-
holders, including representatives from Oxford 
Health Research & Development, clinicians and the 
Clinical Record Interactive System (CRIS) oversight 
committee (which included patient representatives). 
The CRIS system is a research platform across the 
UK that harnesses over 2 million deidentified patient 
records so that data can be used for research and 
audit purposes (https:// crisnetwork. co/). The form 
collects information on whether patients’ consent 
to being contacted about research, including after 
their discharge. It also records whether patients’ 
have capacity to complete the CDPR form.
To understand whether the form would be used 
by clinical staff, and whether this opt-in approach 
was valuable to patients and staff, we developed the 
current study, which also aimed to consider alterna-
tive strategies to engaging patients in research.
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ObjeCTive
Our objectives were: (1) to determine the feasibility of asking all 
clinical staff to use the CDPR form (measured as the proportion 
of patients who had a CDPR form completed on EPR) and (2) to 
collect feedback from staff and patients about their experiences 
and views on the value of the opt-in approach.
MeThOd
study design
This was a mixed methods study consisting of three phases: (1) 
quantitative data capture of the number of patients offered the 
opt-in approach by clinicians (via the CDPR form), (2) an online 
staff survey and (3) qualitative focus groups with patients. The 
study protocol is reported in online supplementary appendix 2.
Access, recruitment and setting
Four pilot sites were selected using convenience sampling. 
The sites were representative of a range of mental health clin-
ical services and patients across the Trust: two memory clinics 
(MCs), an adult mental health team (AMHT) and an acute adult 
ward (AA). Each pilot site consisted of staff with diverse roles 
and varying levels of clinical expertise; all had access to EPR via 
an electronic device or computer.
Phase 1: during an introductory visit at each pilot site by 
researchers, staff were shown the location of the CDPR form 
on EPR, trained how and when to ask the opt-in question and 
were provided with CDPR leaflets with contact details of the 
CDPR study team. Staff were encouraged to develop their own 
implementation strategy regarding when they asked the opt-in 
question (eg, assessment visit, during treatment and discharge).
Phase 2: following completion of phase 1, all staff had partici-
pated were sent an online staff survey to elicit their views on the 
CDPR and opt-in approach.
Phase 3: UK-CRIS was used to search EPR to identify patients 
who had opted-in during phase 1. These patients were contacted 
by phone by a researcher (SW) about taking part in a focus group 
and, if interested, were sent a participant information leaflet by 
email or post. Due to a very low uptake of CDPR at one of the 
pilot sites, focus groups only took place at three of the sites. MC 
patients were invited to attend with a study partner/carer if they 
wished.
data collection
Data collection was undertaken sequentially between the three 
study phases. Phase 1 data were collected between July and 
December 2018, phase 2 data was collected between May and 
June 2019 and phase 3 data was collected in June 2019.
Phase 1: clinical staff discussed the opt-in approach with 
OHFT patients attending clinical services at each of the pilot 
sites, over 6 months. This excluded patients who lacked capacity, 
required a consultee during the discussion or who were under 
the age of 18 years.
Phase 2: staff feedback was collected through an online survey 
sent by email, containing 10 questions about the CDPR form and 
implementation (https://www. surveymonkey. co. uk/ r/ YZ2JVVZ). 
All survey responses were confidential and anonymous. Staff 
were given 1 month to complete the questionnaire, with non-re-
sponders receiving two email reminders.
Phase 3: three separate focus groups were held in meeting 
rooms at the clinical services (AA, MC and AMHT), which were 
familiar to the participating patients. Focus groups were facili-
tated by a researcher (SW) and a member of the clinical team. 
Written informed consent was obtained for all participants, and 
the focus groups were digitally recorded. The groups lasted no 
more than an hour, refreshments were provided and participants 
were reimbursed £20 for participation, plus travel expenses.
Analysis
Phase 1: the UK-CRIS team pulled summary data and ran reports 
on the data held in EPR to establish the total number of patients 
attending each pilot site, the number of CDPR forms completed 
and the number of opt-ins. The age, gender and clinical diag-
nosis for these patients were obtained.
Phase 2: data analysis was conducted using Microsoft Office 
Excel 2013 calculating frequency and corresponding percent-
ages to describe the responses to the survey questions. The Likert 
scale was dichotomised for the purposes of the analysis. A rating 
of either ‘very easy’ or ‘easy’ was regarded as a positive answer, 
‘somewhat easy’ was regarded as a neutral answer and ‘difficult’ 
or ‘very difficult’ was viewed as a negative answer.
Phase 3: the focus group recordings were transcribed by SW; 
data were thematically analysed and managed using the Frame-
work approach.7 Initial codes and categories were grouped and 
regrouped until themes began to emerge, and meetings with 
SW, CH and JP served as a means of triangulating the data by 
ensuring consistency and agreement of the final themes.
Findings
Phase 1
The number of patients attending each pilot site and the relative 
number of CDPR forms completed is summarised in figure 1. 
Across all four pilot sites, 1779 patients attended services during 
the pilot period. Of these, only 197 (11%) had a CDPR form 
completed by staff and 143 (8%) opted-in to being contacted 
about research. Table 1 shows the age, gender and diagnostic 
information for patients attending pilot sites and for patients 
who completed CDPR forms.
Form completion was not evenly spread across the staff who 
participated in the pilot. At the AMHT, one staff member (clin-
ical research assistant) completed 38 out of 53 (72%) forms; of 
these, 97% patients opted-in. At another MC pilot site one staff 
member (nurse) completed 32 out of 68 (47%) forms; of these, 
75% patients opted-in.
Phase 2: summary of staff survey feedback
The questionnaire was sent to 47 members of staff who had 
taken part in phase 1, and the overall response rate was 27 
(57%). Approximately, 17 (63%) were senior clinicians, 6 (22%) 
were junior clinicians, 3 (11%) were research staff and 1 (4%) 
was a member of the administration team. Table 2 shows the 
staff ratings of the CDPR form, the user experience of EPR and 
staff views on implementing the opt-in approach into clinical 
practice.
Phase 3: summary of main themes from patient focus groups
Overall, 18 patients participated in the focus groups. Their 
average age was 48.9 years, and the sample was predominantly 
male (72%) and white British (89%). Patient summary character-
istics are presented in table 3.
The main themes to emerge from the data set about the 
CDPR pilot were ‘patient choice’, ‘trust in the system’, ‘respect 
for patient journey’, ‘perception of research’ and ‘recruitment 
efficiency’.
Patient choice
Some participants said they would immediately know how to 
respond to the opt-in question, while others said they would 
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Figure 1 Number of CDPR forms completed and not completed for total number of patients attending each pilot site from July to December 2018. 
In each box, the large slice of the pie chart on the left shows the number of patients attending each pilot site over 6 months. The small slice represents 
the number of research consent forms completed by these patients. The pie chart of the right illustrates how many patients who completed research 
consent forms opted in (left side) and opted out (right side).
Table 1 Patient through-put, number of CDPR forms completed 
number of opt-ins at each pilot site between July and December 2018
Team name
number of 
patients 
approached
CdPr forms 
completed (%) Opt-ins (%)
Memory clinic 1 64 31 (48.44) 23 (35.94)
Memory clinic 2 527 52 (9.87) 47 (8.92)
Acute adult 91 55 (60.44) 18 (19.78)
Adult mental health team 1097 59 (5.38) 55 (5.01)
Total 1779 197 (11.07) 143 (8.04)
CDPR, consent to discuss their participation in research.
prefer time to consider it and might want more information 
about what taking part in research would involve and the types 
of studies on offer; a few participants indicated that the clinic 
environment might not be the best setting for gathering this 
information:
I wouldn’t say yes or no straight away, I would want to know more 
and then have a think – you might need some time and then come 
back. (AMHT)
I’d feel confident to say no at any time, but it might be nice to think 
about it at home and then answer. (Memory clinic patient (MCP)).
Would be happy to receive a text/letter, with a number to call if you 
wanted to ask questions/get more info. (AA)
Participants generally did not think the choice to opt-in should 
ever be made by a consultee if they did not have capacity:
I would never pick someone else to answer the question. No it’s me 
or that’s it. (AMHT)
Trust in the system
Participants trusted some methods of research contact over 
others and stated a preference for this to be recorded on their 
CDPR form. The majority preferred written contact via an email 
or postal letter:
We get so many people calling us trying to sell solar panels - it’s 
important for you to say who you are and what you want really 
quickly before I put the phone down - maybe a written contact is 
better. (MCP)
Participants did not like being contacted by phone due to an 
intense dislike for calls from unknown numbers:
Don’t like random unknown numbers. Being 'cold called' by a 
researcher is no [better] than being stopped by a chugger on the 
street! (AA)
The reasons for disliking unknown contact from researchers 
by phone depended on the clinical presentation of the patient. 
In the case of the MC patients, they stated it was because they 
were worried that they would forget if they had opted in or not. 
In the case of the AA and AMHT patients, it was reportedly due 
to paranoia:
Makes me sceptical of who is it so I’d just decline it. When I get 
private numbers it makes me nervous especially on bad day and 
feeling really paranoid. (AMHT)
Patient preferences about which staff member asked them the 
CDPR question was based on the level of trust they had with 
different staff members. The MC group had high levels of trust 
in the memory service and ambivalent to who they were asked 
by, whereas inpatient participants reported distrust in clinicians 
(due to being under section or medication disputes) so preferred 
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Table 2 Summary of staff feedback (total number of responses=27)
Positive
n (%)
Middle/indifferent
n (%)
negative
n (%)
CDPR form How familiar are you with what CDPR is? 14 (51.85) 9 (33.33) 4 (14.81)
Do you think that the CDPR form is clear to use? (ie, which parts are compulsory to fill in) 13 (48.14) 6 (22.22) 8 (29.63)
Do you agree with any of the following statements:
 ► The form contains too much information. 1 (3.85)
 ► The form is too long. 2 (7.69)
 ► Iti s not clear what needs to filled out and what can be left blank. 9 (34.62)
 ► The capacity assessment is confusing. 4 (15.38)
 ► It is not clear whether to save or confirm the form. 9 (34.62)
 ► None of the above, 11 (42.31)
Electronic patient records (EPR) Is the form easy to find on EPR? 19 (70.37) 5 (18.52) 3 (11.11)
Would prompts in EPR/other reminders help you to remember to fill in the form? 20 (74.08) 5 (18.52) 2 (7.41)
Implementing into routine practice How easy did you find implementing this form into your routine practice? 12 (44.44) 14 (51.85) 1 (3.70)
Do you agree with any of the following statements?
 ► Hard to identify when it is most appropriate to ask the patient. 4 (14.81)
 ► Hard to get the whole team to use the form, not just one dedicated person. 13 (48.15)
 ► Not a priority/lack of interest from staff. 10 (37.04)
 ► Lack of interest or understanding from patients. 3 (11.11)
 ► Lack of support and resources to trial using the form properly. 2 (7.41)
 ► None of the above. 8 (29.63)
CDPR, consent to discuss their participation in research.
Table 3 Summary characteristics of focus group participants
Memory clinic
Patient: n=5
Carer: n=4 Acute adult n=4 Adult mental health team n=5
Age in years (range) Patient: 68.1 (64–79)
Carer: 65.4 (57–68)
42.3 (34–47) 37.7 (18–41)
Gender   
  Male Patient: 4; carer: 0 4 5
  Female   Patient: 1; carer: 4 0 0
Ethnicity   
  Caucasian 9 4 3
  Other 0 0 2
Clinical diagnoses   
  F00-F09: organic, including symptomatic, mental disorders (includes dementia) Patient: 5; carer: 0 0 0
  F20-F29: schizophrenia, schizotypal and delusional disorders 0 4 2
  F30-F39: mood (affective) disorders (includes depression and bipolar)   0 1 1
  F60-F69: disorders of adult personality and behaviour   0 1 2
Participated in research   
  Yes 0 0 3
  No 9 0 2
being asked by a support worker. The AMHT group indicated 
that they would be more likely to opt-in if they were approached 
by a trusted healthcare professional.
I see my GP more often than coming to AMHT now – so a trusted 
GP is better because the setting is better, it’s more regular and con-
sistent. (AMHT)
Respect for patient journey
The timing of being asked the CDPR question was important 
in terms of respecting when the patient’s clinical needs take 
priority over research and generally during clinical assessments 
was seen as inappropriate:
I don’t think the assessment is the best time - you’re finding out that 
you’ve just got a diagnosis of MCI and all this is going on, for me 
it was upsetting. (MCP)
AMHT and inpatients said that the instability of their admis-
sion and treatment periods meant the CDPR question would be 
best asked at discharge:
At the beginning when I was having serious problems that would 
have been prioritised above talking about research. (AMHT)
The ward is when you're not in a good place. You should be asked 
the question at your discharge session because that it when you are 
in the best place. (AA)
Perception of research
There was limited understanding about the links between research 
and improved treatment and clinical care, but there was general 
consensus that research and improving recruitment was important.
Research is really important, otherwise we’d never get anywhere 
new. If people are given opportunities to be involved in it I think 
it’s a really good thing. (MC-C)
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However, AMHT and AA participants had more negative 
perceptions of research as invasive and highly medicalised:
Research is what the Nazi’s did on people - I don’t want to be a 
guinea pig! (AA)
Most participants did not think that research participation 
should be altruistic and that it should be incentivised, either 
financially or through a guarantee of improved clinical outcome, 
given the potential risks of taking part or being on placebo:
What’s the point in taking part in research if there are irreversible 
side effects or you’re on the sugar pill? (AA)
Recruitment efficiency
Participants highlighted the need for research contact to be effi-
cient by maintaining up to date records of their personal infor-
mation on EPR:
It’s about keeping up with the volunteer group – dynamics of it are 
always moving - people move away, die, don’t want to continue 
– so that you don’t waste your time contacting people who aren’t 
suitable anymore. (MCP)
After discharge to the community team, you might be moved on 
twice so your address will change or you stay with family. (AA)
For MC participants this also included ensuring that the 
contact details of the patient’s carer were accurately recorded 
on EPR (with the patient’s consent), so that any research contact 
could involve them.
Some participants thought that being contacted about research 
was an uncontentious issue, so asking for consent to contact 
caused unnecessary complication and confusion. Many argued 
that although clinical staff did have time to ask the CDPR ques-
tion, research recruitment could be more efficient if the question 
was removed altogether and patients were contacted directly 
by researchers. However, one participant on the inpatient ward 
disagreed:
You should ask this question otherwise people will be bombarded. 
(AA)
disCussiOn
In our study, the majority of patients and staff viewed research 
very positively. The discordance between the generally positive 
views of the opt-in approach and the very low completion rate 
limits the feasibility of CDPR as a strategy to improve access to 
research for real-world patients. This study provides evidence 
that despite both patient and staff beliefs that research is 
important, there are still barriers to translating this into practice.
The barriers identified by staff relating to discussing research 
with patients included perceived lack of time, lack of awareness 
and interest in research and a poor user experience of the EPR 
system. These issues were not raised at monitoring visits, and 
the CDPR team only ever received two emails with queries from 
staff, indicating that they were not a priority to resolve. Previous 
research supports these findings that NHS staff are generally 
demotivated about research,8 and there is a lack of time for 
research activity,9 but these only relate to acute hospital trust 
settings.
The diversity of staff who participated in the study may help 
explain the differences between form completion at each of the 
pilot sites, as research-active staff were more confident talking 
about research and had allocated time to do so. For example, an 
assistant psychologist at an MC who already discusses research 
with patients is likely to find implementing CDPR more feasible 
than a healthcare support worker on an inpatient ward, where 
high acuity, staff handovers and quantity of clinical admin per 
patient is prioritised over research activity. Although the aim of 
CDPR was that all staff would ask the opt-in question, in reality, 
only a handful did so. This implies that protecting time for all 
clinical staff to discuss research with patients may be beneficial.2
The importance of NHS consumers being involved in deci-
sions about how participants are recruited to research is well 
established,10 but to our knowledge, this is the first study of its 
kind to incorporate both patient and staff perspectives, a range 
of clinical settings and both qualitative and quantitative meth-
odologies in solving recruitment challenges in a mental health 
trust setting.
Overall, our conclusion is that while modifications may be 
made to the current opt-in approach in order to improve its 
success, the approach is inherently inefficient. While this study 
only analysed one approach to research recruitment, alternative 
approaches exist, each with their own ethical considerations in 
relation to patient data protection and issues of coercion.11 The 
ethical and practical benefits of an opt-in approach are debat-
able, as it could be argued that this approach leads to only a 
handful of patients being offered opportunities to participate in 
research due to a lack of clinician engagement. In addition, this 
approach can lead to low response rates, wasted resources and 
research of limited scientific validity due to a lack of representa-
tion from the general patient population. Other approaches, such 
as a transparent opt-out approach, whereby patients are offered 
the opportunity to hear about research opportunities unless they 
indicate otherwise, should be considered and would increase the 
likelihood of obtaining representation from the general patient 
population, while still allowing patients to choose whether they 
wish to participate in research.12 Careful consideration of these 
different options is required to ensure that patients’ best interests 
are protected and that mental health patients are being offered 
opportunities to take part in research that might improve their 
healthcare outcomes.
CliniCAl iMPliCATiOns
The potential implications for practice from this study are signif-
icant; if all patients are provided with better access to research, 
both research and clinical outcomes can be improved. Research 
participants would be more representative of the clinical popu-
lation in general, and this would strengthen the evidence base of 
treatment for all patients. If research awareness opportunities 
could be more comprehensively disseminated, this would reduce 
the requirement for clinicians to refer patients to research studies 
and would allow all staff to discuss research with their patients.
By improving the methods of recruiting patients to research 
studies, NHS Trusts can align with the priorities of institutions 
such as the National Institute for Health Research, which aim to 
improve the health and wealth of the nation through research.13 
In addition, they can move towards a clinical service where all 
patients are properly informed about the benefits of taking part 
in research and are provided with equitable access to studies. 
Increasing opportunities for research participation would also 
serve to develop and equip staff with the research skills needed 
to drive research participation forward as their research and 
clinical practice environments become increasingly intertwined. 
This pilot study demonstrates that the evaluation of strategies is 
critically important as we continue to innovate and evolve more 
effective systems of embedding research into real-world practice. 
It is hoped that this study can generate new ideas and strategies 
for other NHS Trusts across the UK and internationally.
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